Sign in | Register
Services
Solutions
About Us
Resources
Contact Us

Webinar – Integrated mRNA & circRNA-tLNP Platform Empowering In Vivo CAR-T Therapies

integrated-mrna-circrna.png

RNA therapeutics and targeted lipid nanoparticles (tLNP) are opening new possibilities for engineering CAR-T cells directly in the body.

 

How can integrated platforms accelerate this innovation?

 

Join our upcoming webinar, discover how combining plasmid development, RNA manufacturing, and targeted LNP delivery can simplify and speed up the journey from concept to therapeutic application.

Lauren-Lu.png
Lauren Lu
Sr. Director, Plasmid Business Dept., ProBio
WeiGuo.png
Wei Guo
Sr. Manager, mRNA PD, ProBio
Time
Topic
14:00-14:40
Development and Manufacturing Strategy for mRNA Template Plasmids
Dr. Lauren Lu, Sr. Director, Plasmid Business Dept., ProBio
Understand where the challenge of mRNA template plasmids production is
Develop proprietary strains, backbone, and robust production process for mRNA template plasmids
Gain insight into industry trends, challenges, and opportunities in the sector
14:40-15:20
Integrated xRNA-tLNP Platform Empowering In Vivo CAR-T Therapies
Dr. Wei Guo, Sr. Manager, mRNA PD Dept., ProBio
Key considerations of xRNA–LNP technology for CAR-T therapy
Technical challenges and solutions to xRNA-tLNP manufacturing
Case study of in vivo CAR-T